Drugs / KHK2823
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02181699 | Jun 2014 → May 2019 | acute myeloid leukemia, myelodysplastic syndrome | Kyowa Kirin, Inc. | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KHK2823 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02181699 ↗ |